Beyond a CDMO, Your Strategic Ally in Advancing Animal Health
Protheragen Vetivio, as a leading CDMO (Contract Development and Manufacturing Organization), is dedicated to being your most trusted partner. We provide clients with one-stop services covering the entire lifecycle of pet drug development, empowering you to overcome bottlenecks and accelerate the R&D process.
Pet Disease Models Learn More
Protheragen Vetivio can develop or screen the most appropriate spontaneous or induced canine and feline disease models based on your drug target and indication. These models highly simulate the disease state in pets in terms of pathophysiology, clinical manifestations, and biochemical indicators.
Preclinical Research
Protheragen Vetivio provides systematic and compliant preclinical research services, generating high-quality, reproducible data to provide critical support for clinical trials.
Learn MoreClinical Research
Protheragen Vetivio's clinical research team understands the specificities of pet clinical trials and offers end-to-end clinical research services, from protocol design to reporting.
Learn More
Manufacturing
Protheragen Vetivio possesses production lines capable of manufacturing various dosage forms, including tablets, capsules, injections, and orally thin films, to meet diverse client needs.
Learn MoreRegulatory Services
Protheragen Vetivio's regulatory affairs expert team is well-versed in global pet drug regulations and provides one-stop regulatory services covering the entire pet drug R&D lifecycle.
Learn More